Top Markets
#1 Trillions Trillions +5,128.12%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +165.63%
#4 Siren Siren +128.69%
#5 inSure DeFi inSure DeFi +59.52%
#6 KONET KONET +56.82%
#7 Aria.AI Aria.AI +45.69%
#8 Banana For Scale Banana For Scale +45.24%
#9 Syndicate Syndicate +40.88%
#10 Janction Janction +36.48%
Coin of the day
Trillions Trillions
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Clasificación en acciones #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Precio por acción
$0.09933121
Capitalización bursátil
$29.15K
Cambio (1 día)
0.57%
Cambio (1 año)
449.49%
País
IE
Comercio Ovoca Bio plc (OVB)

Categoría

Healthcare
Número de acciones en circulación de Ovoca Bio plc (OVB)
Número de acciones en circulación al June 2024: 92.84M
Según los últimos informes financieros y el precio de las acciones de Ovoca Bio plc, el número actual de acciones en circulación es 92.84M. Al final de December 2023, la empresa tenía 75.11M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Ovoca Bio plc (OVB) desde 2001 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
2026 (TTM) 92.84M -99.55%
2024 20.72B 27,488.06%
2023 75.11M -7.91%
2022 81.56M 0.00%
2021 81.56M 0.00%
2020 81.56M 0.00%
2019 81.56M 0.00%
2018 81.56M 0.00%
2017 81.56M 0.00%
2016 81.56M 0.00%
2015 81.56M -6.64%
2014 87.36M 0.00%
2013 87.36M 0.00%
2012 87.36M -0.61%
2011 87.90M -0.64%
2010 88.46M 0.00%
2009 88.46M 1.33%
2008 87.30M 28.36%
2007 68.01M 45.51%
2006 46.74M 129.03%
2005 20.41M 194.39%
2004 6.93M 19.17%
2003 5.82M 1.55%
2002 5.73M 3.94%
2001 5.51M 0.00%
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 4,691.14%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 173.50%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M 10.84%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 104.66%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M -33.84%
NL